Localization of CD44 at the Invasive Margin of Glioblastomas by Immunoelectron Microscopy
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 21 (6) , 517-525
- https://doi.org/10.3109/01913129709016368
Abstract
Glioblastoma multiforme is a highly invasive primary brain tumor, which is known to strongly express the CD44 cell adhesion receptor. A number of experimental studies suggest that the interaction of this receptor with extracellular matrix (ECM) proteins such as hyaluronic acid may in part mediate human glioma cell adhesion and invasion of brain tissue. Although the expression of CD44 and its spliced variants in brain tumors have been extensively studied, there have been no reports localizing its expression to the invasive margin of the tumor. The authors used immunoelectron microscopy to investigate the expression patterns of CD44 in an in vitro organotypic invasion assay. Tumor spheroids initiated from the U373 MG human glioblastoma line were confronted with fetal rat brain aggregates in a spheroid coculture system. The CD44 expression appeared at the interface between glioblastoma tumor spheroids and brain tissue, as well as in the spheroid itself. CD44 immunoreactivity was not detectable in mature 21-day fetal brain aggregates. The findings provide direct evidence that CD44 is expressed at the confrontational invasive border between glioblastomas and brain tissue, further supporting its role in glioma cell-ECM recognition and attachment.Keywords
This publication has 26 references indexed in Scilit:
- Expression of CD44 splice variants in human primary brain tumorsJournal of Neuro-Oncology, 1995
- Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumorsJournal of Neurosurgery, 1995
- Identification of glioma-associated antigen MUC 2-63 as CD44British Journal of Cancer, 1994
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytesExperimental Cell Research, 1992
- Differential expression of the CD44 molecule in human brain tumoursInternational Journal of Cancer, 1992
- Localization of CD44 (P80) on the external surface of a human astrocytoma cellNeuroReport, 1991
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- CD44 — A molecule involved in leukocyte adherence and T-cell activationImmunology Today, 1989
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987